论文部分内容阅读
Hilar cholangiocarcinoma(HCCA)is an aggressive malignancy with a dismal prognosis.The 5-year survival rate has been reported to range from 39%to 50%if an R0 resection is obtained[1].Approximately 25%patients with early stage HCCA of all cases can be treat